Search

Author/Creator Mahadevia, Parthiv

1. Amivantamab compared with real-world therapies in patients with advanced non-small cell lung cancer harboring EGFR exon 20 insertion mutations who progressed after platinum-based chemotherapy. (June 2022)

Authors:
Minchom, Anna; Viteri, Santiago; Bazhenova, Lyudmila; Gadgeel, Shirish M.; Ou, Sai-Hong Ignatius; Trigo, José; Bauml, Joshua M.; Backenroth, Daniel; Bhattacharya, Archan; Li, Tracy; Mahadevia, Parthiv; Girard, Nicolas
Journal:
Lung cancer
Issue:
Volume 168(2022)
Page Start:
74
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Comparative clinical outcomes for patients with advanced NSCLC harboring EGFR exon 20 insertion mutations and common EGFR mutations. (December 2021)

Authors:
Bazhenova, Lyudmila; Minchom, Anna; Viteri, Santiago; Bauml, Joshua M.; Ou, Sai-Hong Ignatius; Gadgeel, Shirish M.; Trigo, José Manuel; Backenroth, Daniel; Li, Tracy; Londhe, Anil; Mahadevia, Parthiv; Girard, Nicolas
Journal:
Lung cancer
Issue:
Volume 162(2021)
Page Start:
154
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Frequency, underdiagnosis, and heterogeneity of epidermal growth factor receptor exon 20 insertion mutations using real‐world genomic datasets. Issue 2 (28th November 2022)

Authors:
Viteri, Santiago; Minchom, Anna; Bazhenova, Lyudmila; Ou, Sai‐Hong Ignatius; Bauml, Joshua M.; Shell, Scott A.; Schaffer, Michael; Gu, Junchen; Rose, Jennifer B.; Curtin, Joshua C.; Mahadevia, Parthiv; Girard, Nicolas
Journal:
Molecular oncology
Issue:
Volume 17:Issue 2(2023)
Page Start:
230
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search